We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$3.67T
AUM Growth
+$273B
(+8%)
Cap. Flow
+$30.8B
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
4,644
New
41
Increased
3,401
Reduced
945
Closed
112
Avg Time Held
6.4
years
Top 10 Avg Time Held
4.6
years
Top 20 Avg Time Held
4.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$2.67B |
| 2 |
Ferguson
FERG
|
+$2.17B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Amazon
AMZN
|
+$1.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$3.16B |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$2.44B |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.51B |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$1.29B |
| 5 |
Y
Alleghany Corp
Y
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Healthcare | 14.85% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 9.67% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4176
Tonix Pharmaceuticals
TNXP
$105M
| $380K | ﹤0.01% |
49
+6
| +14% | +$51.8K |
2019 Q2
14 quarters
|
|
|
NXTP
4177
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
| $372K | ﹤0.01% |
162,489
+1,396
| +0.9% | +$5.29K |
2019 Q1
15 quarters
|
|
4178
BioRestorative Therapies
BRTX
$2.13M
| $371K | ﹤0.01% |
6,752
| – | – |
2021 Q4
4 quarters
|
|
|
SRXH
4179
SRX Global
SRXH
$24.1M
| $368K | ﹤0.01% |
349
| – | – |
2021 Q3
5 quarters
|
|
4180
CervoMed
CRVO
$34.5M
| $368K | ﹤0.01% |
48,509
+28
| +0.1% | +$233 |
2017 Q1
23 quarters
|
|
4181
Wheeler Real Estate Investment Trust
WHLR
$216K
| – | – |
0
| – | – |
2013 Q3
37 quarters
|
|
4182
Nano Dimension
NNDM
$594M
| $365K | ﹤0.01% |
158,487
| – | – |
2021 Q2
6 quarters
|
|
4183
Indaptus Therapeutics
INDP
$350M
| $363K | ﹤0.01% |
8,941
+4
| +0% | +$202 |
2021 Q3
5 quarters
|
|
4184
Docebo
DCBO
$685M
| $363K | ﹤0.01% |
10,941
-14,401
| -57% | -$432K |
2020 Q4
8 quarters
|
|
4185
Beasley Broadcasting Group
BBGI
$17.6M
| $361K | ﹤0.01% |
19,625
-1,846
| -9% | -$37.7K |
2013 Q2
38 quarters
|
|
4186
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
| $361K | ﹤0.01% |
253,882
+117
| +0% | +$193 |
2021 Q1
7 quarters
|
|
4187
Barfresh Food Group
BRFH
$9.62M
| $360K | ﹤0.01% |
276,785
+101
| +0% | +$181 |
2022 Q1
3 quarters
|
|
4188
Cyngn
CYN
$6.98M
| $358K | ﹤0.01% |
39
+1
| +3% | +$11.5K |
2021 Q4
4 quarters
|
|
4189
DELISTED
Venus Concept
VERO
| $355K | ﹤0.01% |
6,723
-2
| -0% | -$90 |
2017 Q4
20 quarters
|
|
|
SRGA
4190
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $354K | ﹤0.01% |
177,793
+82
| +0% | +$202 |
2013 Q2
38 quarters
|
|
|
MGIC
4191
DELISTED
Magic Software Enterprises
MGIC
| $348K | ﹤0.01% |
21,736
+3,852
| +22% | +$61.3K |
2020 Q4
8 quarters
|
|
4192
HCW Biologics
HCWB
$2.73M
| $348K | ﹤0.01% |
758
+361
| +91% | +$186K |
2021 Q4
4 quarters
|
|
4193
Cerenome
CNSY
$13.7M
| $346K | ﹤0.01% |
2,915
+1
| +0% | +$159 |
2020 Q2
10 quarters
|
|
4194
DELISTED
Village Bank and Trust Financial Corp.
VBFC
| $346K | ﹤0.01% |
6,873
-372
| -5% | -$19.4K |
2022 Q2
2 quarters
|
|
4195
Energy Services of America
ESOA
$174M
| $345K | ﹤0.01% |
133,994
+17,274
| +15% | +$47.5K |
2022 Q2
2 quarters
|
|
|
HALL
4196
DELISTED
Hallmark Financial Services, Inc.
HALL
| $344K | ﹤0.01% |
58,832
+37
| +0.1% | +$298 |
2013 Q2
38 quarters
|
|
|
CEMI
4197
DELISTED
Chembio diagnostics, Inc.
CEMI
| $343K | ﹤0.01% |
1,561,470
-544
| -0% | -$163 |
2013 Q2
38 quarters
|
|
4198
BioVie
BIVI
$10.1M
| $337K | ﹤0.01% |
433
+85
| +24% | +$46K |
2021 Q1
7 quarters
|
|
4199
Auddia
AUUD
$5.74M
| $336K | ﹤0.01% |
107
| – | – |
2021 Q2
6 quarters
|
|
4200
DELISTED
Bio-Path Holdings Inc
BPTH
| $335K | ﹤0.01% |
11,083
+7
| +0.1% | +$307 |
2014 Q2
34 quarters
|
|
Similar funds
Vanguard Group's Q4 2022 Portfolio in Review
As of Q4 2022, Vanguard Group held 4,644 positions worth $3.67T, up 8% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 3.3%. Vanguard Group opened 41 new positions and exited 112, leaving the 4,644-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q4 2022 buy was U-Haul Holding Co Series N: 8,844,620 shares worth $486M.
- Vanguard Group added most to Prologis in Q4 2022, an estimated $2.67B increase.
- Vanguard Group's biggest Q4 2022 reduction was McKesson, cutting an estimated $868M.
- Vanguard Group fully exited Twitter, Inc. in Q4 2022, selling an estimated $3.16B.
- Vanguard Group's ten largest holdings make up 18% of its $3.67T portfolio in Q4 2022.
- Vanguard Group opened 41 new positions and closed 112 in Q4 2022.
- Vanguard Group's portfolio value rose 8% quarter-over-quarter to $3.67T.
Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.